Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine

In present study the immediate and long-term therapy results of 14 patients with refractory chronic lymphocytic leukemia (CLL) are analyzed. Treatment program included alemtuzumab alone or in combination with fludarabine.

Saved in:
Bibliographic Details
Main Authors: E. V. Kataeva, A. K. Golenkov, E. V. Trifonova, G. A. Dudina, T. A. Mitina, L. L. Vysotskaya, T. D. Lutskaya, I. V. Buravtsova, R. V. Gorenkov, Yu. Yu. Chuksina, V. V. Yazdovskiy
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/95
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839574497260208128
author E. V. Kataeva
A. K. Golenkov
E. V. Trifonova
G. A. Dudina
T. A. Mitina
L. L. Vysotskaya
T. D. Lutskaya
I. V. Buravtsova
R. V. Gorenkov
Yu. Yu. Chuksina
V. V. Yazdovskiy
author_facet E. V. Kataeva
A. K. Golenkov
E. V. Trifonova
G. A. Dudina
T. A. Mitina
L. L. Vysotskaya
T. D. Lutskaya
I. V. Buravtsova
R. V. Gorenkov
Yu. Yu. Chuksina
V. V. Yazdovskiy
author_sort E. V. Kataeva
collection DOAJ
description In present study the immediate and long-term therapy results of 14 patients with refractory chronic lymphocytic leukemia (CLL) are analyzed. Treatment program included alemtuzumab alone or in combination with fludarabine.
format Article
id doaj-art-d57836c8e8bb4e5080ac6ce12f081036
institution Matheson Library
issn 1818-8346
2413-4023
language Russian
publishDate 2014-07-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj-art-d57836c8e8bb4e5080ac6ce12f0810362025-08-04T13:57:48ZrusABV-pressОнкогематология1818-83462413-40232014-07-01624710.17650/1818-8346-2011-6-2-4-7110Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabineE. V. Kataeva0A. K. Golenkov1E. V. Trifonova2G. A. Dudina3T. A. Mitina4L. L. Vysotskaya5T. D. Lutskaya6I. V. Buravtsova7R. V. Gorenkov8Yu. Yu. Chuksina9V. V. Yazdovskiy10M.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteIn present study the immediate and long-term therapy results of 14 patients with refractory chronic lymphocytic leukemia (CLL) are analyzed. Treatment program included alemtuzumab alone or in combination with fludarabine.https://oncohematology.abvpress.ru/ongm/article/view/95chronic lymphocytic leukemiaresistant patientsalemtuzumabfludarabine
spellingShingle E. V. Kataeva
A. K. Golenkov
E. V. Trifonova
G. A. Dudina
T. A. Mitina
L. L. Vysotskaya
T. D. Lutskaya
I. V. Buravtsova
R. V. Gorenkov
Yu. Yu. Chuksina
V. V. Yazdovskiy
Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
Онкогематология
chronic lymphocytic leukemia
resistant patients
alemtuzumab
fludarabine
title Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
title_full Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
title_fullStr Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
title_full_unstemmed Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
title_short Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
title_sort treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab alone or in combination with fludarabine
topic chronic lymphocytic leukemia
resistant patients
alemtuzumab
fludarabine
url https://oncohematology.abvpress.ru/ongm/article/view/95
work_keys_str_mv AT evkataeva treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine
AT akgolenkov treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine
AT evtrifonova treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine
AT gadudina treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine
AT tamitina treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine
AT llvysotskaya treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine
AT tdlutskaya treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine
AT ivburavtsova treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine
AT rvgorenkov treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine
AT yuyuchuksina treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine
AT vvyazdovskiy treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine